Skip to content
MedsAcross

Medicine

Vincristine 2 mg/2 mL injection

Vincristine · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Vincristine 2 mg/2 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store Upright.

Key facts

Active ingredient (INN)
Vincristine
Brand
Sold under the generic name
Strength
2 mg/2 mL
Dosage form
Injection
Route
Intravenous
Packs
1 vial of 2 mL
Manufacturer
Hospira
Origin register
US FDA, United States
Storage
Store Upright.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L01CA02 Vincristine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 January 1996
Identifiers
RxCUI 1863343, 1863354DailyMed set ID b22e4c8e-dbe1-4d4b-a026-e1812974071c, 49596de6-ab18-49d1-9e5b-30968fc21c36NDC 61703-309Application ANDA071484

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose61703-309-16Hospira1 January 1996
1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose61703-309-25Hospira27 November 2013

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 10 July 1963Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Vincristine

Clinical summary

Vincristine is a vinca alkaloid indicated in acute leukemia. It is available as injection for intravenous use. MedsAcross supplies Vincristine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Vincristine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Vincristine 2 mg/2 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.